What question did this study set out to answer?

February 11, 2026Clinical Pharmacokinetics1 citationsOpen Access

Evaluation and Improvement of Specialized Vancomycin Pharmacokinetic Models for Pediatric Cardiovascular Intensive Care Unit and Pediatric Oncology Patients

MMMichael G. McCarthyGavekal Intelligence Software (France)RKRon J. KeizerCanon (Japan)JHJasmine H. HughesCanon (Japan)

Key Points

This study aims to evaluate the effectiveness of specialized vancomycin pharmacokinetic models for pediatric patients in ICU and oncology settings.
Comparison of pharmacokinetic models developed for pediatric subpopulations and general populations.
Assessment of model fit-for-purpose on individual case bases.
Analysis of clinical performance metrics of specialized versus general models.
Both specialized and general pharmacokinetic models showed acceptable clinical performance.
The effectiveness of pharmacokinetic models varies and should be assessed individually.
No single model type was found to be superior across all pediatric cases.

Abstract

Population pharmacokinetic models developed on distinct pediatric subpopulations are not necessarily more fit-for-purpose than models developed on a general population. Both well-specified general models and specialized models may be capable of achieving suitable clinical performance in these subpopulations, and this assessment of model fit-for-purpose must be made on a case-by-case basis.

问 AI

Bookmark

View Full Paper

Cite This Study

McCarthy et al. (Mon,) studied this question.

synapsesocial.com/papers/698c1bef267fb587c655df91 https://doi.org/https://doi.org/10.1007/s40262-026-01623-7

问 AI

Bookmark

View Full Paper